Navigation Links
Hiemstra Appoints Daniel C. Rosenman as Vice President of Research & Development
Date:3/25/2008

Furthers firm design and development efforts that focus on usability and

rapid commercialization

SAN FRANCISCO, March 25 /PRNewswire/ -- Hiemstra Product Development, an innovative, product design and development company, serving the life sciences industry, today announced the appointment of Daniel C. Rosenman as Vice President of Research & Development. As the company continues to expand, Dan furthers Hiemstra's commitment to the design and engineering of medical technologies that focus on usability and rapid commercialization.

Dan joins Hiemstra with over 16 years of R&D, operations, clinical, regulatory and quality systems experience in the life sciences industry. He has developed novel medical technologies in diverse clinical areas including general surgery, gynecology, orthopedics, urology, cardiac surgery, interventional cardiology, and ophthalmology, in both large companies and early-stage ventures. He began his life science career as an R&D engineer, specializing in bioabsorbable polymers, with Ethicon, Inc., a Johnson & Johnson company. Dan was one of the early employees at med tech start-ups, Heartport, Inc. and BioCardia, Inc., where he led the R&D efforts from the initial founding, to financing and through commercialization. Dan was the first employee at Transcend Medical, Inc., a venture-backed ophthalmic company. Within months of joining Transcend, he completed research, development and clinical milestones that resulted in series A funding. Dan holds over 27 U.S. patents in the medical field and has other global patents pending. He has co-authored several scientific and clinical publications in collaboration with clinical leaders at Stanford University, Massachusetts General Hospital, and HELIOS Hospital, Siegburg, Germany.

"My passion is to enable clients to develop their novel medical technologies for clinicians and, ultimately, patients," explains Rosenman. "At Hiemstra, our unique product development process delivers that. Our industrial and mechanical design teams are fully-integrated and focused on human factors that result in elegant solutions that go far beyond just clinical utility."

Doug Hiemstra, President, Hiemstra Product Development stated, "Dan adds tremendous value to our company and our customers. He brings a strong track record of successfully moving medical technologies from concept to development through commercialization."

About Hiemstra:

Hiemstra Product Development is an innovative medical product design and development company, serving the life sciences industry. Founded in 1991, this San Francisco-based firm is built on its unparalleled integration of industrial design and development, with a unique focus on usability. The company's production facilities provide for device assembly and rapid commercialization. Hiemstra's veteran team's experience spans a broad range of clinical areas and applications, and clients include start-ups to Fortune 500 companies. A description of services can be found at http://www.hiemstra.com.


'/>"/>
SOURCE Hiemstra Product Development
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hiemstra Approved to Manufacture Medical Devices in New CER
2. AMICAS Appoints Joseph D. Hill to Its Board of Directors and Promotes Kevin C. Burns to Senior Vice President and Chief Financial Officer
3. Digirad Corporation Appoints John W. Sayward to Its Board of Directors
4. NutraCea Appoints New Chief Financial Officer
5. Transplant Network Appoints Cynthia Siljestrom CEO
6. Solera Holdings, Inc. Appoints Jason Brady as General Counsel
7. The Childrens Hospital of Philadelphia Appoints New Chief Nursing Officer
8. InnerPulse, Inc. Appoints Elsa Chi Abruzzo as Vice-President of Regulatory and Quality Affairs
9. Ventas Appoints James D. Shelton and Robert D. Reed to Board
10. Crdentia Appoints Randall Turnbull to Senior Vice President and Chief Clinical Officer
11. China Sky One Medical, Inc. Appoints Four Independent Board Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment ... new clinical and scientific initiatives have all marked the last 12 months at ... and CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps ... in Dover, NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally ... one hour from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure ... search for and donate to Give To Cure’s campaign that is crowdfunding clinical trials ... users make and share payments through a smart device. In 2015 alone, Venmo processed ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Dr. Justin ... announce their 2nd Annual No Cost Dental Day to individuals in need. The event ... purpose of this No Cost Dental Day is to provide dental care to community ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016  SciClone Pharmaceuticals, Inc. ... it has entered into a settlement agreement with ... fully resolving the SEC,s investigation into possible violations ... the terms of the settlement agreement, SciClone has ... including disgorgement, pre-judgment interest and a penalty.  This ...
(Date:2/4/2016)... Feb. 4, 2016 Global Immunology Market ... to drive long-term market growth Summary ... of chronic disorders that affect 5–7% of western ... of their symptoms and key patient demographics, they ... immune pathways and an inappropriate immune response. Generally, ...
(Date:2/4/2016)... DIEGO, Feb. 4, 2016  Aethlon Medical, Inc. ... affinity biofiltration devices to treat life-threatening diseases, today ... 2016 ended December 31, 2015. ... objectives set forth in our last quarterly call, ... reinforce our long-term objective to establish the Aethlon ...
Breaking Medicine Technology: